1. 711PHepatocellular carcinoma and liver metastasis treated by hafnium oxide nanoparticles activated by stereotactic body radiation therapy. (23rd October 2018) Authors: Pracht, M; Chajon, E; de Baere, T; Nguyen, F; Bronowicki, J-P; Vendrely, V; Baumann, A-S; Croisé-Laurent, V; Rio, E; Rolland, Y; Le Sourd, S; Gustin, P; Perret, C; Mornex, F; Peiffert, D; Merle, P; Deutsch, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PD-002A phase I/II trial of hafnium oxide nanoparticles activated by radiotherapy in hepatocellular carcinoma and liver metastasis. (20th June 2018) Authors: Chajon, E; Pracht, M; De Baere, T; Nguyen, F; Bronowicki, J; Vendrely, V; Baumann, A; Croisé-Laurent, V; Rio, E; Rolland, Y; Le Sourd, S; Gustin, P; Perret, C; Mornex, F; Peiffert, D; Merle, P; Deutsch, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PD-002A phase I/II trial of hafnium oxide nanoparticles activated by radiotherapy in hepatocellular carcinoma and liver metastasis. (20th June 2018) Authors: Chajon, E; Pracht, M; De Baere, T; Nguyen, F; Bronowicki, J; Vendrely, V; Baumann, A; Croisé-Laurent, V; Rio, E; Rolland, Y; Le Sourd, S; Gustin, P; Perret, C; Mornex, F; Peiffert, D; Merle, P; Deutsch, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗